Dr. Asir Kopic

Dr. Asir Kopic
Asir Kopic MD
  • Name: Kopic
  • Surname: Asir
  • Date of Birth: 20 Oct 1963
  • Address: Loeffelstr. 3, D-70597 Stuttgart
  • Citizenship:Germany
  • Phone: +49 711 18422140
  • Fax: +49 711 18422149
  • Email: med@dr-kopic-stuttgart.de

Education:

1979-1982
Elementary school, Teslic, B&H
10/1983 – 12/1989
Medical Faculty, Tuzla, B&H
25.05.1990
(MD) doctor promotion
11.03.1991
The State exam at Federal Ministry of Health, Sarajevo, B&H
01.07.1994
Permission for using MD title from the Germany Ministry for scientific research, Stuttgart
19.08.1998
German medical approbation, awarded by the State Ministry of Germany, Stuttgart
21.06.2003
Internal Medicine specialist examination, Medical Chamber Westfalen Lippe, Germany-Muenster
20.11.2004
Hematology and oncology subspecialty examination, Medical Chamber Westfalen Lippe, Germany-Muenster
09.12.2006
Gastroenterology subspecialty examination, Medical Chamber Westfalen Lippe, Germany-Muenster

Others:

19.11.1999
The certification for emergency medicine, Doctors chamber Baden Wuerttemberg, Stuttgart, Germany
20.04.2001
Certificate for conventional diagnostic methods in radiology, Doctors chamber Westfalen Lippe, Muenster, Germany
10.09.2003
Certificate for bronchoscopy, Doctors chamber Westfalen Lippe, Muenster, Germany

Work Experience:

12/1989 – 12/1991
Internship in u Health Centre „ Dr.Jurinac“, Teslic, B&H
01/1992 – 06/1994
Temporary work as medical technician in Karl-Olga-Krankenhaus, Germany – Stuttgart, where I graduated secondary medical school.
07/1994 – 05/1999
Department doctor in the field of internal medicine, hematology and oncology, Fachklinik, Germany –Kornwestheim
06/1999 – 12/2004
Scientific assistant in the field of internal medicine, hematology and oncology at the University Clinic Marienhospital der Ruhr – Bochum University, Germany
01-08/2005
Department doctor in the field of internal medicine, hematology, oncology and gastroenterology, Katholisches Krankenhaus Dortmund-West, Germany
09/2005 – 09/2006
Department doctor of internal medicine, hematology, oncology and gastroenterology at Johanneshospital – Dortmund, Germany
10-12.2006
Department doctor of internal medicine and gastroenterology at JZU UKC University Clinical Centre Tuzla, B&H
01.2007 – 12.2008
Chief Physician of the Clinic for internal medicine, oncology, hematology and gastroenterology Fachklinik Leonardis, Germany – Bad Heilbrunn
01/2009 – 12/2011
Director of Clinic for oncology, hematology and radiotherapy and
team leader for bone marrow transplantation (EBMT CIC 0647) at JZU UKC University Clinical Centre, Tuzla, B&H
01.2012 – 03.2014
Chief Physician of the Clinic for internal medicine, oncology, hematology and gastroenterology, Private Oncology Clinic HALLWANG, Germany-Dornstetten-Hallwangen
Since 01.04.2014
Establishment Physicians for internal medicine, oncology, hematology and gastroenterology, Germany-Stuttgart
Private oncological Daily clinic

Publications:

26.02.1998
Verbesserung der Zytostatikatoleranz durch L-Ornthinaspartat, DBI Der Bayerische Inernist 1998; 1: 54-60
2011
Emina K, Elmir C, Asir K et al., Morphometric Angiogenesis Parameters for Indolent and Aggressive non-Hodgkin`s Lymphoma. Med Arh.2011; 65(1):9-12
2010-2011
Principal Investigator of the Study A4061051 (`Phase II Open-label Safety Extension Study Tenezumab in Cancer patients with Pain Due to Bone Metastases`)
2011
Klinische und Labor prognostische Parameter des großzelligen B-Zell Lymphom,Hämatologen und Transfusiologen Kongress BH (2011.), Abstractbuch
2011
Frühkomplikationen nach Stammzelltransplantation durch Konditionierung, Hämatologen und Transfusiologen Kongress BH (2011.), Abstractbuch
2011
Bericht über siebenjährige klinische Erfahrungen der hämatopoetischen Stammzelltransplantation, Abteilung für Hämatologie, Uni-Klinik Tuzla, Hämatologen und Transfusiologen Kongress BH (2011.), Abstractbuch
2011
Monitoring der CMV-Infektion nach der hämatopoetischen Stammzelltransplantation, Hämatologen und Transfusiologen Kongress BH (2011.), Abstractbuch
2011
Erfolgreiche Behandlung von aplastischer Anämie, Hämatologen und Transfusiologen -Kongress BH (2011.), Abstractbuch
2011
Morphometric Angiogenesis Parameters for Indolent and Aggresive Non-Hodgkins Lymphoma Hematologica ,16th Congress of the European Hematology Association, (2011.)
2011
H Baldomero, M Gartwohl, A Gartwohl et al., The EBMT activity survey 2009: trends over the past 5 years. BMT 2011; 46:458-501
2012
Corelation of Namber of Circulating Tumor Cells, Chemotherapy and Clinical Development in Breast Cancer Patients, 18 th Conference of Clinical Oncology Athens. 28-29.April 2012
2012
Corelation of Namber of Circulating Tumor Cells and Clinical Development in Patients with Breast Cancer of Several Stages, 18 th Conference of Clinical Oncology Athens. 28-29.April 2012
2012
Can cancer Stem Cell-Like Cells Determine a Therapeutic Model in Breast Cancer Patients when any other recommended Therapy failed in this Group? Considerations and Signal Cases,18 th Conference of Clinical Oncology Athens. 28-29. April 2012
2012
Evaluation of clinical Development of two Patients with Urinary Bladder Cancer before and after Chemotherapy, 18 th Conference of Clinical Oncology Athens. 28-29. April 2012
2012
SR Passweg, H Baldomero, A Gratwohl et al., The EBMT activity survey: 1990-2010. BMT 2012; 47:906-923
2012
Corelation between FOLFOX regime and stemness in colon CSCs, ESMO, Gastrointestinal cancer Barcelona Spain. 27-30.June 2012
2012
Cancer stem cell-like cells: a therapeutic model in breast cancer patients, where any other recommended therapy has failed, 37 th ESMO Congress Viena Austria, 28.8.-02.10.2012
Since 10/
Stady of Val432Leu polymorphism in breast and colon cancer, compared to the 2012 response inchmotherapy
2013
Is there any correlation between the number change in circulating tumor cells and the clinical evaluation in cancer patients?, 19 th Conference of clinical oncology Athens. 16-20. April 2013
2013
The role of AP-1 in colon cancer stem cells. M Chatziioannou, P Apostolou, M Toloudi Eloannou, A Kopic, D Komiotis, I Papasotiriou., J Clinic Oncol 31, (suppl;abstr e 14699)
2013
With CD44 dipeptidyl peptidase-IV, hepatocyte growth factor recepter and the Study of the interreaction among Notch pathway receptors, correlation with stemness, as well as ther interaction SETMAR transferase in colon cancer stem cells, P Apostolou, M Toloudi Eloannou, E Kourtidou, M Chatziioannou, A Kopic, D Komiotis, C Kiritsis, S Manta, I Papasotiriou., Journal of Receptors and Signal Transduction, 2013; 33(6):353-358
2013
P-0166 The Study of gene expression as a tool for predicting response to chemotherapy in pancreatic cancer, A Panagiotis, M Toloudi Eloannou, M Chatziioannou, A Kopic, D Komiotis, I Papasotiriou, Annals of Oncology, 2013; 24(4):83

Membership:

German Medical Association
European Community for bone marrow transplantation
European Leukemia Net, Members of WP8-MDS, 2012
R.G.C.C. (Research Genetic Cancer Center)

Languages:

Bosnian-Croatian-Serbian , English and Russian languages